SAR407899
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAR407899, covering 2011-05-02 to 2019-07-11. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI [Phase 2]